Singapore Prime Minister Lee Hsien Loong announced on 5 June 2020 while participating in 'Global Vaccine Summit 2020' that Singapore is building up its vaccine manufacturing capacity in order to offer fill and finish contract manufacturing services to vaccine developers.

"We have contributed about US$13 million towards international efforts to combat COVID-19, through the WHO, CEPI, and donations of essential medical equipment and supplies" said PM Lee.

"We are investing heavily in research and development on diagnostics, vaccines and therapeutics. Our researchers have developed a range of serological and nucleic acid-based diagnostic tests, which have been deployed to over 20 countries. They are also developing therapeutic monoclonal antibodies as well as a vaccine, and have started clinical trials of various therapeutics" he added.

"The new vaccine manufacturing capacity should help them ramp up production faster, and assure them high standards of safety and quality in the manufacturing process" said PM Lee. 

"Discovering, producing and distributing a safe and effective vaccine is vital to get life back to normal despite COVID-19. I hope that this summit will help focus our minds and resources, and forge partnerships to promote “vaccine multilateralism” , he concluded.